US awards $1.6 billion to Novavax for Covid-19 vaccine

The US on Tuesday announced it was providing $1.6 billion in funding for the development and manufacture of a Covid-19 vaccine candidate produced by biotech firm Novavax, the largest amount awarded under Operation Warp Speed.